2024
Ductal hamartoma of the pancreas: A clinicopathologic study
Das D, Gonzalez I, Yeh M, Wu T, Jain D. Ductal hamartoma of the pancreas: A clinicopathologic study. Human Pathology 2024, 153: 105669. PMID: 39362530, DOI: 10.1016/j.humpath.2024.105669.Peer-Reviewed Original ResearchConceptsPancreatectomy specimensPancreatic mucinous cystic neoplasmsConsecutive pancreatic resectionsVariable cystic changesCyst fluid CEAHigh-grade dysplasiaMucinous cystic neoplasmsClinical suspicionPancreatic resectionAbdominal symptomsPancreatic carcinomaPatient ageClinicopathological featuresCystic changesLow columnar epitheliumSquamous metaplasiaCystic neoplasmsCystic lesionsProliferative lesionsClinicopathological studyDuctal structuresColumnar epitheliumPancreatectomyLesionsLuminal secretions
2023
Coexistent Sjogren’s syndrome and Birt-Hogg-Dube´ syndrome: a case report
Lin Y, Guo T, Lei C, Yang B, Yang D, Luo H, Peng H. Coexistent Sjogren’s syndrome and Birt-Hogg-Dube´ syndrome: a case report. BMC Pulmonary Medicine 2023, 23: 460. PMID: 37993820, PMCID: PMC10664354, DOI: 10.1186/s12890-023-02680-5.Peer-Reviewed Original ResearchConceptsSjogren's syndromeBirt-HoggMultiple thin-walled cystic lesionsDiffuse cystic lung diseasesThin-walled cystic lesionsShortness of breathCystic lung diseaseLabial gland biopsyDry eyeLower lungCystic changesCystic lesionsLung diseasePhysical examinationCase reportGland biopsyDube syndromeRare caseComputed tomographyDubé syndromeInsufficient evidenceSyndromeDiagnostic algorithmLungRespiratory sounds
2020
T-cell and NK-cell lymphomas in the lung
Pan Z, Xu ML. T-cell and NK-cell lymphomas in the lung. Seminars In Diagnostic Pathology 2020, 37: 273-282. PMID: 32448591, DOI: 10.1053/j.semdp.2020.04.003.Peer-Reviewed Original ResearchConceptsT-cell lymphomaWorld Health Organization classificationNK-cell lymphomasAdequate antibiotic therapyTypical radiologic featuresPrinciples of treatmentDifferent histologic typesPrecise pathologic diagnosisHilar adenopathyEmpirical antibioticsSystemic lymphomaWedge biopsyAntibiotic therapyLymphomas accountRadiologic featuresRadiologic findingsBronchoscopic examinationHistologic typePleural effusionClinical symptomsRecurrent infectionsCystic changesOrganization classificationPathologic diagnosisPulmonary opacities
2019
Frequent Use of Local Therapy Underscores Need for Multidisciplinary Care in the Management of Patients With Melanoma Brain Metastases Treated With PD-1 Inhibitors
Qian JM, Yu JB, Mahajan A, Goldberg SB, Kluger HM, Chiang VLS. Frequent Use of Local Therapy Underscores Need for Multidisciplinary Care in the Management of Patients With Melanoma Brain Metastases Treated With PD-1 Inhibitors. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: 1113-1118. PMID: 31479702, DOI: 10.1016/j.ijrobp.2019.08.053.Peer-Reviewed Original ResearchConceptsBrain metastasesLocal therapyNeurologic safetyMelanoma patientsProspective phase 2 trialProgressive brain metastasesSerial brain imagingMelanoma brain metastasesPD-1 inhibitorsPhase 2 trialRapid disease progressionManagement of patientsNeurologic symptomsMultidisciplinary careTrial enrollmentCystic changesClinical trialsDisease progressionPatientsLesion sizeMetastasisMultidisciplinary teamTumor growthTherapyClinical decision
2012
BRAF V600E mutation in papillary thyroid microcarcinoma: a genotype–phenotype correlation
Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML. BRAF V600E mutation in papillary thyroid microcarcinoma: a genotype–phenotype correlation. Modern Pathology 2012, 26: 62-70. PMID: 22918165, DOI: 10.1038/modpathol.2012.152.Peer-Reviewed Original ResearchConceptsPapillary thyroid microcarcinomaThyroid microcarcinomaPapillary thyroid carcinomaFollicular variantThyroid carcinomaLateral cervical node metastasesOsteoclastic-type giant cellsCervical node metastasisInfiltrative tumor borderGroup of tumorsBRAF V600E mutationClassic nuclear featuresGenotype-phenotype correlationStromal calcificationLymphovascular invasionNode metastasisClinicopathologic featuresLymphocytic infiltrationAggressive featuresTumor sizeCystic changesPapillary microcarcinomaAbsence of mutationsHigh prevalenceMicrocarcinomaMicrocystic Serous Cystadenoma of the Pancreas With Subtotal Cystic Degeneration
Panarelli N, Park K, Hruban R, Klimstra D. Microcystic Serous Cystadenoma of the Pancreas With Subtotal Cystic Degeneration. The American Journal Of Surgical Pathology 2012, 36: 726-731. PMID: 22498822, DOI: 10.1097/pas.0b013e31824cf879.Peer-Reviewed Original ResearchConceptsMicrocystic serous cystadenomaPancreatic serous cystadenomaSerous cystadenomaPancreatic pseudocystCystic degenerationDifferential diagnosis of pancreatic massesDiagnosis of pancreatic massesPredominant histologic featureBenign cystic neoplasmDegenerative cystic changesMacrocystic serous cystadenomaJohns Hopkins HospitalFibrotic cyst wallTumor volumePancreatic massPathology archivesCystic changesCystic neoplasmsPancreatic neoplasmsCystadenomaDifferential diagnosisHistological featuresMyofibroblast proliferationMultilocular casesRadiographic studies
2000
Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential.
Klimstra D, Wenig B, Heffess C. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Seminars In Diagnostic Pathology 2000, 17: 66-80. PMID: 10721808.Peer-Reviewed Original ResearchConceptsSolid pseudopapillary tumorLow malignant potentialMalignant potentialCarcinoma of low malignant potentialNeoplasm of low malignant potentialPresence of disseminated diseaseMetastasis to liverCystic pancreatic tumorsDegenerative cystic changesDisseminated diseaseAlpha 1-antitrypsinCystic carcinomaPancreatic tumorsClinical presentationCystic changesLonger survivalHypervascular regionPancreatic cell typesTumorPathological featuresBiological behaviorGland formationYoung womenCell typesMicroscopic appearance
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply